A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naïve people with type 2 diabetes: A randomized, controlled trial

  1. Heise, T.
  2. Tack, C.J.
  3. Cuddihy, R.
  4. Davidson, J.
  5. Gouet, D.
  6. Liebl, A.
  7. Romero, E.
  8. Mersebach, H.
  9. Dykiel, P.
  10. Jorde, R.
Aldizkaria:
Diabetes Care

ISSN: 0149-5992,  1935-5548

Argitalpen urtea: 2011

Alea: 34

Zenbakia: 3

Orrialdeak: 669-674

Mota: Artikulua

DOI: 10.2337/DC10-1905 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus